
|Podcasts|June 25, 2020
ARVO 2020: Two-year anatomical outcomes of FAc in DME patients
Author(s)Alex Delaney-Gesing
Advertisement
Victor Gonzalez, MD, speaks with Ophthalmology Times® David Hutton on the highlights of his presentation regarding "Two-year outcomes from the PALADIN Phase 4 study: Anatomic/functional changes and reduced treatment frequency associated with 0.19 mg of fluocinolone acetonide implant (FAc) with persistent or recurrent diabetic macular edema," during the 2020 Association for Research in Vision and Ophthalmology (ARVO) virtual meeting.
Advertisement
Latest CME
Advertisement
Advertisement






















